Last Round
Seed
Oct 27, 2026
Total Funding Raised
$12.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Atlas Bio operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was a Seed round in October 2026.
Atlas Bio is a biotechnology company that provides a secure, agentic AI platform for life-science research and development, focusing on gene therapy and clinical intelligence.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Compliance & Risk
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlas Bio Comparables
Compare Atlas Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Big Picture Bio | 83% | |
| Lir Therapeutics | 81% | |
| Cradle | 77% |
For institutional investors. Book with your work email.
Atlas Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Atlas Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creandum | Seed |
| First Momentum Ventures | Seed, Pre Seed |
| LEA Partners | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2026
$10M raised, led by Creandum.
For institutional investors. Book with your work email.
Atlas Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atlas Bio's valuation, stock price, and market status.
Is Atlas Bio a public or private company?
Atlas Bio is a private company.
What is the current stock price of Atlas Bio?
Atlas Bio is a private company, so its shares have no public market price. Caplight tracks Atlas Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atlas Bio worth (valuation)?
Valuation information for Atlas Bio is not publicly available.
Can I buy Atlas Bio stock?
Atlas Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atlas Bio's last funding round?
Atlas Bio's most recent funding round was Seed on October 27, 2026.
Who are the main investors in Atlas Bio?
Key investors in Atlas Bio include Creandum, First Momentum Ventures, LEA Partners.
Will Atlas Bio IPO soon?
No public IPO plans have been announced for Atlas Bio.
How can I track Atlas Bio secondary market activity?
Caplight tracks bids, offers, and trades in Atlas Bio's shares on secondary markets.